全文获取类型
收费全文 | 14644篇 |
免费 | 985篇 |
国内免费 | 590篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 283篇 |
妇产科学 | 334篇 |
基础医学 | 2887篇 |
口腔科学 | 587篇 |
临床医学 | 1081篇 |
内科学 | 2219篇 |
皮肤病学 | 297篇 |
神经病学 | 1317篇 |
特种医学 | 306篇 |
外国民族医学 | 2篇 |
外科学 | 1349篇 |
综合类 | 1655篇 |
现状与发展 | 1篇 |
预防医学 | 707篇 |
眼科学 | 326篇 |
药学 | 1572篇 |
中国医学 | 155篇 |
肿瘤学 | 1049篇 |
出版年
2023年 | 83篇 |
2022年 | 142篇 |
2021年 | 332篇 |
2020年 | 243篇 |
2019年 | 370篇 |
2018年 | 356篇 |
2017年 | 339篇 |
2016年 | 367篇 |
2015年 | 429篇 |
2014年 | 657篇 |
2013年 | 937篇 |
2012年 | 761篇 |
2011年 | 889篇 |
2010年 | 780篇 |
2009年 | 856篇 |
2008年 | 872篇 |
2007年 | 851篇 |
2006年 | 760篇 |
2005年 | 742篇 |
2004年 | 620篇 |
2003年 | 556篇 |
2002年 | 441篇 |
2001年 | 416篇 |
2000年 | 328篇 |
1999年 | 285篇 |
1998年 | 211篇 |
1997年 | 208篇 |
1996年 | 176篇 |
1995年 | 197篇 |
1994年 | 182篇 |
1993年 | 127篇 |
1992年 | 144篇 |
1991年 | 135篇 |
1990年 | 132篇 |
1989年 | 108篇 |
1988年 | 77篇 |
1987年 | 73篇 |
1986年 | 53篇 |
1985年 | 137篇 |
1984年 | 167篇 |
1983年 | 113篇 |
1982年 | 114篇 |
1981年 | 117篇 |
1980年 | 83篇 |
1979年 | 76篇 |
1978年 | 52篇 |
1977年 | 51篇 |
1976年 | 27篇 |
1975年 | 12篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Age-related cognitive decline is the major cause of concern due to its 70% more incidence than dementia cases worldwide. Moreover, aging is also the major risk factor of Alzheimer's disease (AD), associated with progressive memory loss. Approx. 13 million people will have Alzheimer-related memory decline by 2050. Learning and memory is the fundamental process of brain functions. However, the mechanism for the same is still under investigation. Thus, it is critical to understand the process of memory consolidation in the brain and extrapolate its understanding to the memory decline mechanism. Research on learning and memory has identified several molecular signatures such as Protein kinase M zeta (PKMζ), Calcium/calmodulin-dependent protein kinase II (CaMKII), Brain-derived neurotrophic factor (BDNF), cAMP-response element binding protein (CREB) and Activity-regulated cytoskeleton-associated protein (Arc) crucial for the maintenance and stabilization of long-term memory in the brain. Interestingly, memory decline in AD has also been linked to the abnormality in expressing these memory-related molecular signatures. Hence, in the present consolidated review, we explored the role of these memory-related molecular signatures in long-term memory consolidation. Additionally, the effect of amyloid-beta toxicity on these molecular signatures is discussed in detail. 相似文献
2.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(5):803-811
ObjectivesTo review the evidence pertaining to the association between cow’s milk protein allergy and recurrent acute otitis media and otitis media with effusion.MethodsThe CENTRAL, Web of Science, EMBASE, MEDLINE, LILACS databases, and gray literature were searched.ResultsFour studies were included, identifying the prevalence rates: 0.2% of delayed speech due to chronic otitis media with effusion in 382 children with cow’s milk protein allergy, 10.7% of cow’s milk protein allergy in 242 children who underwent ENT procedures, 40% of cow’s milk protein allergy in 25 children with recurrent otitis media with effusion and higher tendency to otitis media in children with cow’s milk protein allergy of 186 children (1.5 + 0.6 vs. 0.4 + 0.1; p < 0.1).ConclusionConsidering the characteristics and methodological variations of the identified studies, it is not possible to state that there is reliable evidence of an association between cow’s milk protein allergy and otitis media. 相似文献
3.
目的 探讨扶正化瘀方含药血清对肝星状细胞(HSC)激活素A(activinA)/smad信号通路活化的影响。方法 20只SD大鼠按照随机数字表法分为对照组及扶正化瘀(Fzhy)-低、中、高剂量含药血清组,每组5只,分别以蒸馏水,0.75、1.5、3.0 g/kg扶正化瘀溶液(扶正化瘀胶囊药物粉末与蒸馏水配制)灌胃1次/d,连续3 d,取血制备空白血清(对照组)和含药血清。以大鼠HSC-T6细胞为研究对象,分别用5%、10%、20%体积分数的各组含药血清培养细胞。CCK-8检测细胞存活率,选取细胞存活率在50%左右的体积分数重新分为对照组及Fzhy-低、中、高剂量组。流式细胞术检测细胞周期及凋亡率、线粒体膜电位变化和活性氧(ROS)水平;实时荧光定量聚合酶链反应检测细胞中activinA、smad3、samd7、核因子(NF)-κB的mRNA水平;蛋白质印迹法检测细胞中activinⅡA受体(ActRⅡA)、smad3、NF-κB p65、胱天蛋白酶(caspase)-3的蛋白水平。结果 各扶正化瘀含药血清组的细胞存活率均低于对照组(P<0.05),选择体积分数为10%的含药血清进行后续实验。对照组和各扶正化瘀方含药血清组细胞周期和凋亡率差异均无统计学意义。对照组及Fzhy-低、中、高剂量组细胞内ROS水平及线粒体膜电位水平降低比例逐次升高(P<0.05)。与对照组比较,Fzhy-中、高剂量组smad3 mRNA表达水平降低,smad7 mRNA升高,Fzhy-低、中、高剂量组NF-κB、activinA mRNA,smad3、NF-κB p65、ActRⅡA蛋白表达水平降低,Fzhy-低剂量组、中剂量组caspase-3蛋白表达水平升高(P<0.05);与Fzhy-低剂量组相比,Fzhy-中、高剂量组smad3 mRNA表达水平降低,Fzhy-中剂量组activinA及smad7 mRNA升高(P<0.05)。结论 扶正化瘀方含药血清可通过影响HSC-T6细胞增殖、参与细胞的氧化应激以及调节细胞activinA/smad信号转导通路来实现抗纤维化作用。 相似文献
4.
5.
6.
RongZong Liu WonShik Choi Saket Jain Deepak Dinakaran Xia Xu Woo Hyun Han XiaoHong Yang Darryl D. Glubrecht Ronald B. Moore Hlne Lemieux Roseline Godbout 《Molecular oncology》2020,14(12):3100
Early stage localized prostate cancer (PCa) has an excellent prognosis; however, patient survival drops dramatically when PCa metastasizes. The molecular mechanisms underlying PCa metastasis are complex and remain unclear. Here, we examine the role of a new member of the fatty acid‐binding protein (FABP) family, FABP12, in PCa progression. FABP12 is preferentially amplified and/or overexpressed in metastatic compared to primary tumors from both PCa patients and xenograft animal models. We show that FABP12 concurrently triggers metastatic phenotypes (induced epithelial‐to‐mesenchymal transition (EMT) leading to increased cell motility and invasion) and lipid bioenergetics (increased fatty acid uptake and accumulation, increased ATP production from fatty acid β‐oxidation) in PCa cells, supporting increased reliance on fatty acids for energy production. Mechanistically, we show that FABP12 is a driver of PPARγ activation which, in turn, regulates FABP12''s role in lipid metabolism and PCa progression. Our results point to a novel role for a FABP‐PPAR pathway in promoting PCa metastasis through induction of EMT and lipid bioenergetics.
Abbreviations
- AR
- androgen receptor
- ATP
- adenosine triphosphate
- CN
- copy number
- CPT1
- carnitine palmitoyltransferase I
- CS
- citrate synthase
- EMT
- epithelial–mesenchymal transition
- ET
- electron transfer‐state
- FABP
- fatty acid‐binding protein
- LD
- lipid droplet
- OA
- oleic acid
- PCa
- prostate cancer
- PPAR
- peroxisome proliferator‐activated receptor
- PPRE
- peroxisome proliferator‐activated receptor response element
- TZD
- thiazolidinediones
7.
Eric Wang Sydney X. Lu Alessandro Pastore Xufeng Chen Jochen Imig Stanley Chun-Wei Lee Kathryn Hockemeyer Yohana E. Ghebrechristos Akihide Yoshimi Daichi Inoue Michelle Ki Hana Cho Lillian Bitner Andreas Kloetgen Kuan-Ting Lin Taisuke Uehara Takashi Owa Raoul Tibes Iannis Aifantis 《Cancer cell》2019,35(3):369-384.e7
8.
目的 制备吸附重组戊型肝炎病毒(hepatitis E virus,HEV)P179抗原的海藻酸钠/壳聚糖微球混悬制剂,并观察其免疫效果。方法 乳化法制备海藻酸钠/壳聚糖微球,采用不同海藻酸钠浓度、混合乳化剂添加量、混合乳化剂亲水亲油平衡值设计正交试验,确定最佳制备工艺参数。将重组HEV P179抗原吸附在最佳工艺制备的微球表面,制备吸附重组HEV P179的海藻酸钠/壳聚糖微球混悬制剂,皮下多点免疫BALB/c小鼠,测定其诱导小鼠产生特异性IgG抗体的能力,与同剂量含弗氏佐剂的重组HEV P179免疫制剂对比。结果 经正交试验确定乳化最佳工艺参数为:海藻酸钠质量分数1%、混合乳化剂体积分数2%,混合乳化剂亲水亲油平衡值4。制备的微球平均粒径为6.73 μm(分布范围3.90~9.10 μm,方差1.78 μm),形态较为均一,透射电镜观察结果与双层球体及内部疏松多孔的微球结构特点相符。用此条件制备抗原质量浓度为500 μg/ml的混悬制剂,微球对抗原的吸附率为90.64%。免疫效果观察试验结果表明,皮下多点免疫试验中微球制剂诱导特异性IgG抗体的能力优于含弗氏佐剂抗原。结论 成功制备了吸附重组HEV P179的海藻酸钠/壳聚糖微球混悬制剂,且诱导产生特异性IgG抗体的能力优于含弗氏佐剂抗原,为其在新型实验动物超敏制剂中的应用奠定了基础。 相似文献
9.
Managing traumatic liver injury (TLI) is always challenging and demands precise clinical judgment. Currently, treatment of TLI in most circumstances is non-operative; however, surgical therapy might be required for severe TLI, particularly those that result in extensive blood loss. In the current institutional study carried out from June 1995 to April 2017, we describe our experience with 5 patients who received an orthotopic liver transplant for severe TLI. One patient passed away postoperatively from cerebral edema; 1 patient died of renal failure 4 years after the liver transplantation, and 3 patients are still alive. Based on our experience, we conclude that in patients with TLI, especially those with uncontrollable bleeding or those who develop liver failure, liver transplantation should be taken into consideration. 相似文献
10.
ObjectivesAlthough intracellular signaling pathways of insulin-like growth factor I (IGF-I) related to the proliferation of dental pulp cells have been investigated, the switching mechanism from cell proliferation to differentiation during odontogenesis remains elusive. This study aimed to elucidate the role of IGF binding protein (IGFBP) 3 and 5 in regulation of IGF-I during odontoblast differentiation in mouse incisors.MethodsThe detailed expression patterns of IGF-I, IGF-I receptor (IGF-IR), IGFBP3, and IGFBP5 together with that of an odontoblast differentiation marker, nestin, were examined by immunohistochemistry and/or in situ hybridization using paraffinized sections of TetOP-H2B-GFP mouse incisors at postnatal 4 weeks.ResultsUndifferentiated dental papilla cells and preodontoblasts (preOB) showed intense IGF-I- and IGF-IRα-positive reactions, and the expression was observed in differentiated odontoblasts, such as immature odontoblasts (iOB) and mature odontoblasts (mOB). IGFBP3/Igfbp3 was transiently expressed in preOB and early iOB, and the intensity of expression gradually reduced with the progression of odontoblast differentiation. In contrast, immunohistochemical analysis for IGFBP5 identified a positive reaction in the undifferentiated dental papilla cells and differentiated odontoblasts, and the expression of Igfbp5 was reduced in the differentiated odontoblasts.ConclusionThe present study demonstrated the expression patterns of IGF-I, IGF-IR, IGFBP3, and IGFBP5 during odontoblast differentiation in mouse incisors. These results suggested that IGFBP3 regulates the transition from the proliferative to differentiation stage by inhibiting the action of IGF-I on the proliferation of dental papilla cells, and that IGFBP5 plays an important role in the maintenance of the differentiated odontoblasts during tooth development. 相似文献